跳至主要内容
临床试验/NCT05039437
NCT05039437已完成不适用

Development of Green Mei Products for the Prevention of Metabolic Syndrome

Chung Shan Medical University2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Change the blood pressure after intervention

研究概览

简要总结

The aim of this study is to investigate the antihypertensive effects of Mei-Gin formula-4 (MGF-4) and Mei-Gin formula-7.

详细描述

It's a randomized, and single-blind trial and was designed to evaluate the effects of MGFs (MGF-4 and MGF-4) on blood pressure. 50 participants with hypertension (systolic blood pressure between 130-179 mmHg or diastolic blood pressure between 85-109 mmHg) who did not accept any hypertension medication were randomized allocated to either MGF-4 or MGF-7 group. Participants were instructed to take 4 capsules of MGF-4 or MGF-7 daily throughout the duration of the 8 weeks intervention study. After treatment, the change of the blood pressure and relative mechanism were analyzed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The age of the subject is 20 to 70 years old.
  • The subject is a patient with hypertension (SBP is between 130-179 mmHg, DBP is between 85-109mmHg, one of the two can be diagnosed), and there are no serious illnesses requiring hospitalization during the study period treatment.
  • No hypertension medication.
  • The subject can understand the test process described in the consent form and the possible potential risks and benefits, and able to sign the consent form.
  • The subjects shall observe diet control during the trial period.

排除标准

  • Subjects diagnosed with cancer and still under active treatment.
  • Subjects diagnosed with heart disease and still under active treatment.
  • Other drugs are used, whose pharmacological effects may affect blood pressure or may aggravate the effects of drugs.
  • Subjects who have systemic infection and need systemic antibiotics.

结局指标

主要结局

Change the blood pressure after intervention

时间窗: Week 0, 4 and 8

Compare the difference of own SBP and DBP between the week 0, 4 and 8 in each groups

次要结局

  • Change from baseline serum MDA and TEAC at Week 8(Week 0 and 8)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验